Fundraising Fox
/Companies
Sign in

ForCast Orthopedics

Denver, US · Delaware corporation · 2 known investors

Find your way into ForCast Orthopedics

Each arrow is one introduction. Sign up to fill in the first one.

509 people can intro you to Peter

Ask Reid Rubsamen to introduce you to Peter Noymer

You →Reid · together at Aradigm Corporation →Peter

Sign up to find every way you can get introduced to ForCast Orthopedics

  • Your email: who you already know at ForCast Orthopedics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ForCast Orthopedics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

ForCast Orthopedics develops treatments for periprosthetic joint infections using a proprietary targeted drug delivery platform designed to replace the standard of care. The company serves orthopedic surgeons and joint replacement patients seeking improved outcomes for this serious infection complication.

BiotechHealthtechMedical Devices

Founders & leadership

PNPeter Noymer
Peter NoymerExecutive Chairman and CEOPeter Noymer has 25 years of pharmaceutical and medical device industry experience, including roles in clinical and regulatory strategy, FDA/EMA submissions, and product commercialization across multiple therapeutic areas such as pulmonology, endocrinology, cardiology, neurology, and ophthalmology. He is currently Executive Officer and Director at ForCast Orthopedics.
JF
Jared ForanNamed on SEC filing

Board

TO
Terry OpgenorthBoard director
CD
Charles DeCookBoard director

Investors · 2

Also in the syndicate · 2

OrthoInnovationsleadOrthoInnovations LLClead

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 1 round · 2025

▶$3.8MraisedAug 2025 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter NoymerExecutive Officer, Director
  • Jared ForanExecutive Officer, Director
  • Terry OpgenorthDirector
  • Charles DeCookDirector
Offering amount
$10M
Amount sold
$3.8M
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Sparta BiomedicalSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.

Companies working in the same space as ForCast Orthopedics.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase II2020$1.2M
National Science FoundationPhase I2019$224.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

ForCast Orthopedics Announces Initial Close of Series a Financing Round to Advance Novel Therapies for PJI - BioSpacebiospace.com · Aug 2025ForCast Orthopedics Holds Initial Close of Series A Financingfinsmes.com · Aug 2025

Frequently asked questions

What does ForCast Orthopedics do?
ForCast Orthopedics develops treatments for periprosthetic joint infections using a proprietary targeted drug delivery platform designed to replace the standard of care. The company serves orthopedic surgeons and joint replacement patients seeking improved outcomes for this serious infection complication.
How much funding has ForCast Orthopedics raised?
ForCast Orthopedics has disclosed $3.8M raised across 1 round.
Where is ForCast Orthopedics headquartered?
ForCast Orthopedics is headquartered in Denver, US.